Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...

Becton, Dickinson's stock momentum is improving, but geopolitical risks and global headwinds warrant caution. Click here to ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $237.38 which represents a slight increase of $1.08 or 0.46% from the prior close of $236.3. The stock opened at $236.51 and ...

Becton Dickinson and Co (BDX) stock saw a decline, ending the day at $232.59 which represents a decrease of $-3.21 or -1.36% from the prior close of $235.8. The stock opened at $237 and touched a low ...

EVP Shana Carol Neal sold 788 shares of the firm’s stock in a transaction on Tuesday, January 7th. The stock was sold at an ...

Becton, Dickinson & Co shares are currently trading up about 1.1% on the day. The chart below shows the one year performance of BDX shares, versus its 200 day moving average: ...

Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the ...

The 3.5L EcoBoost engine has been around long enough that there are several performance upgrades owners can choose from. Here ...

Charting, Price Performance, News & Related Contracts.

Becton, Dickinson and Company BDX, popularly known as BD ... The optimism led by a solid fourth-quarter fiscal 2024 performance and a few strategic deals are expected to contribute further.

Charting, Price Performance, News & Related Contracts.